Ki-67 inhibitors belong to a class of chemical compounds that have gained significant attention in the realm of cellular research and biological studies. These inhibitors are designed to target a specific protein known as Ki-67, which plays a vital role in cellular processes related to proliferation. Ki-67 is a nuclear protein that is widely used as a marker to assess the proliferative activity of cells, particularly in the context of cancer research. The primary function of Ki-67 is associated with its involvement in cell cycle progression, specifically during the active phases of cell division. It is found in the nucleus of cells during interphase, a phase of the cell cycle when cells are not actively dividing.
The inhibitors designed to target Ki-67 act by modulating its function and interfering with its role in promoting cell proliferation. These compounds often work at a molecular level, interacting with the protein's structure or its binding partners. By inhibiting Ki-67, researchers aim to gain a better understanding of the mechanisms underlying cell division and proliferation. This class of inhibitors holds great promise for shedding light on the intricate molecular processes that govern cell cycle progression. Furthermore, the study of Ki-67 inhibitors can contribute to a deeper comprehension of cellular dynamics and may have implications in various fields of cellular and molecular biology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $315.00 | ||
Inhibits CDK4/6, leading to cell cycle arrest in G1 phase. | ||||||
Ribociclib | 1211441-98-3 | sc-507367 | 10 mg | $450.00 | ||
Selectively inhibits CDK4/6, causing G1 cell cycle arrest. | ||||||
Abemaciclib | 1231929-97-7 | sc-507342 | 10 mg | $110.00 | ||
Blocks CDK4/6 activity, arresting cells in the G1 phase. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $92.00 $260.00 | 42 | |
Inhibits CDK2/5/7, affecting cell cycle progression. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $254.00 | 41 | |
Non-selective CDK inhibitor, inducing cell cycle arrest. | ||||||
Dinaciclib | 779353-01-4 | sc-364483 sc-364483A | 5 mg 25 mg | $242.00 $871.00 | 1 | |
Potent inhibitor of CDK1/2/5/9, causing cell cycle arrest. | ||||||
AT7519 | 844442-38-2 | sc-364416 sc-364416A sc-364416B sc-364416C | 5 mg 10 mg 100 mg 1 g | $207.00 $246.00 $1025.00 $3065.00 | 1 | |
Multi-CDK inhibitor, inducing G2/M phase cell cycle arrest. | ||||||
SNS-032 | 345627-80-7 | sc-364621 sc-364621A | 5 mg 10 mg | $169.00 $262.00 | ||
CDK2/7/9 inhibitor, causing cell cycle arrest and apoptosis. | ||||||
Zotiraciclib | 937270-47-8 | sc-507450 | 10 mg | $202.00 | ||
Dual CDK9/FLT3 inhibitor, impacting cell cycle and signaling. | ||||||